Annual CFO
-$33.46 M
-$5.89 M-21.36%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual cash flow from operations is -$33.46 million, with the most recent change of -$5.89 million (-21.36%) on December 31, 2023.
- During the last 3 years, LRMR annual CFO has risen by +$8.74 million (+20.71%).
- LRMR annual CFO is now -47.40% below its all-time high of -$22.70 million, reached on December 31, 2019.
Performance
LRMR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$24.55 M
-$10.56 M-75.48%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly cash flow from operations is -$24.55 million, with the most recent change of -$10.56 million (-75.48%) on September 30, 2024.
- Over the past year, LRMR quarterly CFO has dropped by -$10.56 million (-75.48%).
- LRMR quarterly CFO is now -317.59% below its all-time high of -$5.88 million, reached on September 30, 2022.
Performance
LRMR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$58.29 M
-$15.35 M-35.74%
September 30, 2024
Summary
- As of February 6, 2025, LRMR TTM cash flow from operations is -$58.29 million, with the most recent change of -$15.35 million (-35.74%) on September 30, 2024.
- Over the past year, LRMR TTM CFO has dropped by -$15.35 million (-35.74%).
- LRMR TTM CFO is now -553.38% below its all-time high of -$8.92 million, reached on March 31, 2020.
Performance
LRMR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LRMR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | -75.5% | -35.7% |
| 3 y3 years | +20.7% | -75.5% | -35.7% |
| 5 y5 years | -47.4% | -75.5% | -35.7% |
LRMR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | +20.5% | -317.6% | at low | -112.2% | at low |
| 5 y | 5-year | -47.4% | +20.7% | -317.6% | at low | -553.4% | at low |
| alltime | all time | -47.4% | +20.7% | -317.6% | at low | -553.4% | at low |
Larimar Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.55 M(+75.5%) | -$58.29 M(+35.7%) |
| Jun 2024 | - | -$13.99 M(+34.4%) | -$42.94 M(+18.2%) |
| Mar 2024 | - | -$10.41 M(+11.4%) | -$36.32 M(+8.5%) |
| Dec 2023 | -$33.46 M(+21.4%) | -$9.34 M(+1.6%) | -$33.46 M(+8.7%) |
| Sep 2023 | - | -$9.20 M(+24.9%) | -$30.79 M(+12.1%) |
| Jun 2023 | - | -$7.37 M(-2.5%) | -$27.47 M(-0.4%) |
| Mar 2023 | - | -$7.55 M(+13.2%) | -$27.59 M(+0.1%) |
| Dec 2022 | -$27.57 M | -$6.67 M(+13.5%) | -$27.57 M(-4.3%) |
| Sep 2022 | - | -$5.88 M(-21.5%) | -$28.82 M(-18.0%) |
| Jun 2022 | - | -$7.49 M(-0.6%) | -$35.14 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.53 M(-4.9%) | -$38.43 M(-8.7%) |
| Dec 2021 | -$42.10 M(-0.2%) | -$7.92 M(-35.1%) | -$42.10 M(-4.4%) |
| Sep 2021 | - | -$12.20 M(+13.1%) | -$44.04 M(+2.3%) |
| Jun 2021 | - | -$10.78 M(-3.8%) | -$43.07 M(-3.2%) |
| Mar 2021 | - | -$11.21 M(+13.7%) | -$44.48 M(+5.4%) |
| Dec 2020 | -$42.20 M(+85.9%) | -$9.86 M(-12.2%) | -$42.20 M(+30.5%) |
| Sep 2020 | - | -$11.22 M(-8.0%) | -$32.34 M(+53.1%) |
| Jun 2020 | - | -$12.20 M(+36.7%) | -$21.12 M(+136.7%) |
| Mar 2020 | - | -$8.92 M | -$8.92 M |
| Dec 2019 | -$22.70 M | - | - |
FAQ
- What is Larimar Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Larimar Therapeutics?
- What is Larimar Therapeutics annual CFO year-on-year change?
- What is Larimar Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly CFO year-on-year change?
- What is Larimar Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Larimar Therapeutics?
- What is Larimar Therapeutics TTM CFO year-on-year change?
What is Larimar Therapeutics annual cash flow from operations?
The current annual CFO of LRMR is -$33.46 M
What is the all time high annual CFO for Larimar Therapeutics?
Larimar Therapeutics all-time high annual cash flow from operations is -$22.70 M
What is Larimar Therapeutics annual CFO year-on-year change?
Over the past year, LRMR annual cash flow from operations has changed by -$5.89 M (-21.36%)
What is Larimar Therapeutics quarterly cash flow from operations?
The current quarterly CFO of LRMR is -$24.55 M
What is the all time high quarterly CFO for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly cash flow from operations is -$5.88 M
What is Larimar Therapeutics quarterly CFO year-on-year change?
Over the past year, LRMR quarterly cash flow from operations has changed by -$10.56 M (-75.48%)
What is Larimar Therapeutics TTM cash flow from operations?
The current TTM CFO of LRMR is -$58.29 M
What is the all time high TTM CFO for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM cash flow from operations is -$8.92 M
What is Larimar Therapeutics TTM CFO year-on-year change?
Over the past year, LRMR TTM cash flow from operations has changed by -$15.35 M (-35.74%)